← All companies
10x Genomics, Inc.
TXG - CIK 0001770787
Market cap$3.72 B
Rank#1634
SEC filings652
The table below shows 10x Genomics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | $344.07M | $359.28M | $219.75M | $587.45M | $663.60M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $47.01M | $87.86M | $114.83M | $104.21M | $85.25M | $51.21M |
| Inventory | $56.34M | $83.11M | $73.71M | $81.63M | $59.97M | $29.96M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.